Cargando…

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toy...

Descripción completa

Detalles Bibliográficos
Autores principales:	FURUTA, Yousuke, KOMENO, Takashi, NAKAMURA, Takaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Academy 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713175/ https://www.ncbi.nlm.nih.gov/pubmed/28769016 http://dx.doi.org/10.2183/pjab.93.027

Ejemplares similares

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018)

Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
por: Caroline, Amy L., et al.
Publicado: (2014)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015)

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
por: Mendenhall, Michelle, et al.
Publicado: (2011)

Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
por: Cai, Lei, et al.
Publicado: (2017)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
por: Jin, Zhinan, et al.
Publicado: (2013)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
por: Tani, Hideki, et al.
Publicado: (2016)

Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus
por: Kato, Hirofumi, et al.
Publicado: (2021)

Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
por: Song, Rui, et al.
Publicado: (2019)

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
por: Tani, Hideki, et al.
Publicado: (2018)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
por: Bringas, Mauro, et al.
Publicado: (2022)

Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020)

Identification of a Broad-Spectrum Viral Inhibitor Targeting a Novel Allosteric Site in the RNA-Dependent RNA Polymerases of Dengue Virus and Norovirus
por: Yi, Dongrong, et al.
Publicado: (2020)

Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
por: Bassetto, Marcella, et al.
Publicado: (2019)

Broad-Spectrum Drugs Against Viral Agents
por: Christopher, Mary E., et al.
Publicado: (2008)

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
por: Wang, Yeming, et al.
Publicado: (2020)

Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
por: Shannon, Ashleigh, et al.
Publicado: (2020)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
por: Naydenova, Katerina, et al.
Publicado: (2021)

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
por: Shannon, A., et al.
Publicado: (2020)

An evaluation of the Hitachi 705 analyser
por: Ferré, C., et al.
Publicado: (1984)

Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV
por: Fujii, Hikaru, et al.
Publicado: (2022)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir
por: Zhang, Yumin, et al.
Publicado: (2023)

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
por: Gowen, Brian B., et al.
Publicado: (2008)

Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
por: Peng, Qi, et al.
Publicado: (2021)

Inhibition of Viral RNA-Dependent RNA Polymerases by Nucleoside Inhibitors: An Illustration of the Unity and Diversity of Mechanisms
por: Barik, Sailen
Publicado: (2022)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Dalcetrapib: JTT 705; JTT-705; R 1658; R1658; RG1658; RO 4607381; RO4607381
Publicado: (2012)

Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections
por: Huchting, Johanna
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fku5qtc6f4jr2hbj141d24qv1q